Your browser doesn't support javascript.
loading
Management of fever and neutropenia in children with cancer.
Vedi, A; Pennington, V; O'Meara, M; Stark, K; Senner, A; Hunstead, P; Adnum, K; Londall, W; Maurice, L; Wakefield, Claire; Cohn, R J.
Afiliação
  • Vedi A; Kids Cancer Centre, Sydney Children's Hospital, High Street, Randwick, NSW, 2031, Australia, a.vedi@unsw.edu.au.
Support Care Cancer ; 23(7): 2079-87, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25533581
ABSTRACT

PURPOSE:

Febrile neutropenia remains a common, life-threatening complication of chemotherapy in paediatric oncology. Delays in institution of empiric antibiotics have been identified at tertiary and regional centres caring for these patients and associated with decreased survival. Our objective was to reduce the time to administration of empiric antibiotics to less than 60 min from the time of presentation to hospital.

METHODS:

A retrospective study of the records of oncology patients presenting to the emergency department of a tertiary hospital over a 3-month period was performed and time to first antibiotic administration recorded. Potential causes of delay in commencement of antibiotics were identified and an algorithm-based approach to the management of fever in immunocompromised children developed and implemented. Follow-up evaluation data were collected at 12 and 60 months post-intervention. Causes of delay in commencement of antibiotics at regional hospitals that share care with the tertiary hospital were identified through questionnaires, interviews and focus groups, involving patients and medical and nursing staff. The impact of the introduction of the algorithm at one peripheral hospital was evaluated.

RESULTS:

The mean time to empiric antibiotics was reduced from 148 min (95% confidence interval (CI) 81-216) at baseline to 76 min (95% CI 50-101) at 12 months post-intervention and sustained at 65 min (95% CI 52-77) 5 years after the intervention. At the peripheral hospital, mean time to antibiotic delivery was reduced from 221 min (95% CI 114-328) to 65 min (95% CI 42-87) at 12 months after the intervention.

CONCLUSION:

The introduction of the guideline, with teaching and support for staff and parents, resulted in an improvement in practice, meeting international guidelines and achieving sustained results at 5 years after introduction at a tertiary hospital. The guideline has been shown to be feasible and effective at a regional hospital.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neutropenia Febril Induzida por Quimioterapia / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neutropenia Febril Induzida por Quimioterapia / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2015 Tipo de documento: Article